- Home
- CHEK vs ADIL Comparison
CHEK vs ADIL Comparison
Compare CHEK & ADIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CHEK
- ADIL
- Stock Information
- Founded
- CHEK 2004
- ADIL 2010
- Country
- CHEK Israel
- ADIL United States
- Employees
- CHEK N/A
- ADIL N/A
- Industry
- CHEK Medical Electronics
- ADIL Biotechnology: Pharmaceutical Preparations
- Sector
- CHEK Health Care
- ADIL Health Care
- Exchange
- CHEK Nasdaq
- ADIL Nasdaq
- Market Cap
- CHEK 4.4M
- ADIL 4.8M
- IPO Year
- CHEK 2015
- ADIL 2018
- Fundamental
- Price
- CHEK N/A
- ADIL $0.32
- Analyst Decision
- CHEK
- ADIL Strong Buy
- Analyst Count
- CHEK 0
- ADIL 1
- Target Price
- CHEK N/A
- ADIL $8.00
- AVG Volume (30 Days)
- CHEK 28.3K
- ADIL 23.2M
- Earning Date
- CHEK 08-14-2025
- ADIL 08-12-2025
- Dividend Yield
- CHEK N/A
- ADIL N/A
- EPS Growth
- CHEK N/A
- ADIL N/A
- EPS
- CHEK N/A
- ADIL N/A
- Revenue
- CHEK N/A
- ADIL N/A
- Revenue This Year
- CHEK N/A
- ADIL N/A
- Revenue Next Year
- CHEK N/A
- ADIL N/A
- P/E Ratio
- CHEK N/A
- ADIL N/A
- Revenue Growth
- CHEK N/A
- ADIL N/A
- 52 Week Low
- CHEK $0.56
- ADIL $0.22
- 52 Week High
- CHEK $3.04
- ADIL $3.00
- Technical
- Relative Strength Index (RSI)
- CHEK 41.81
- ADIL 41.13
- Support Level
- CHEK $0.75
- ADIL $0.27
- Resistance Level
- CHEK $0.86
- ADIL $0.40
- Average True Range (ATR)
- CHEK 0.03
- ADIL 0.06
- MACD
- CHEK 0.00
- ADIL 0.01
- Stochastic Oscillator
- CHEK 19.59
- ADIL 34.48
About CHEK Check-Cap Ltd.
Check-Cap Ltd is a clinical-stage medical diagnostics company engaged in the development of an ingestible imaging capsule that utilizes low-dose X-rays for the detection and imaging of colonic polyps and colorectal cancers, or CRC. The company is developing C-Scan, the first capsule-based system for preparation-free, colorectal cancer screening. Its scanning capsule will be swallowed and propelled by natural motility through the gastrointestinal tract and excreted naturally with no need for retrieval for data collection. The operations of the company are presently located in Israel, but it currently expects to market products in the United States, Europe, Israel and Japan.
About ADIL Adial Pharmaceuticals Inc
Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company develops prescription medications for addiction and related disorders. Its lead product is AD04, which is for the treatment of alcohol use disorder. The active ingredient in AD04 is ondansetron, a serotonin-3 antagonist.